🕵️ SANA Biotechnology, Inc. ($SANA)
SEC insider & ownership activity, last 12 months · CIK 1770121 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Blackrock, Inc. added 4.9% → 5.1%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Robert Nelsen | 17.3% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Fund IX, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Fund IX Overage, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Fund X, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Fund X Overage, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners IX, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners IX Overage, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners X Overage, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners X, L.P. | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners IX, LLC | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| ARCH Venture Partners X, LLC | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Keith Crandell | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Clinton Bybee | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Steven Gillis | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Kristina Burow | 17.2% | 13G | Nov 14, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 6.3% | 13G | May 21, 2026 | filing ↗ | |
| Peter Kolchinsky | 6.3% | 13G | May 21, 2026 | filing ↗ | |
| Rajeev Shah | 6.3% | 13G | May 21, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 6.3% | 13G | May 21, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.1% | 13G | Jan 21, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Other events (8.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Apr 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 10, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Other events (8.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 4, 2025 | filing ↗ |
| Other events (8.01) | Sep 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 28, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 6, 2025 | filing ↗ |
| Other events (8.01) | Aug 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |
| Other events (8.01) | Aug 6, 2025 | filing ↗ |